Emcure Pharmaceuticals is set to launch its IPO on July 3. The risk factors listed in draft IPO papers are manufacturing or quality control problems, failure to comply with quality standards, operational risks, disruptions to supply or rise in pricing of raw materials, among others. These factors may affect company's business. Emcure also highlighted the extensive government regulations.